Theranexus (EPA:ALTHX) | Finanzwire

Basculer en Français

10776	Companies
232462	Keywords
160931	Articles
123791	Press releases

Home
Companies
Theranexus

PRESS RELEASE

published on 12/17/2024 at 18:00, 1 year 7 months ago

THERANEXUS AND EXELTIS (INSUD PHARMA) ANNOUNCE LICENSING AGREEMENT TO COMMERCIALIZE THERANEXUS TX01 FOR TWO RARE NEUROLOGICAL DISORDERS
Theranexus and Exeltis sign license agreement for TX01, expanding treatment for rare neurological diseases. Exeltis to market TX01 across Europe and other regions

License Agreement Theranexus Neurological Diseases Exeltis TX01
BRIEF

published on 11/19/2024 at 18:05, 1 year 8 months ago

Theranexus presents positive results for the treatment of Batten disease CLN3

Clinical Trial Theranexus Batten-1 Batten Disease Visual Acuity
PRESS RELEASE

published on 11/19/2024 at 18:00, 1 year 8 months ago

Update on the Theranexus' Batten-1 project in CLN3 Batten's disease
Theranexus and BBDF present positive results of Batten-1 trial in CLN3 Batten disease patients, showing safety and efficacy of miglustat. Expanded use indicates potential in visual acuity stabilization

Theranexus BBDF Batten-1 Trial CLN3 Batten Disease Miglustat
BRIEF

published on 10/23/2024 at 18:05, 1 year 9 months ago

Theranexus Announces Its Cash Position as of September 30, 2024

Treasury Batten Disease Miglustat Research Tax Credit Industrial Partnerships
PRESS RELEASE

published on 10/23/2024 at 18:00, 1 year 9 months ago

THERANEXUS ANNOUNCES ITS CASH POSITION AS OF SEPTEMBER 30, 2024
Theranexus reports €1.9 million cash position as of September 30, 2024, with plans for product registrations and phase 3 trials in rare neurological diseases

Cash Position Biopharmaceutical Theranexus Rare Neurological Diseases Product Registrations
BRIEF

published on 10/17/2024 at 18:05, 1 year 9 months ago

Theranexus partners with Synerlab for a breakthrough in the treatment of Niemann-Pick C

Theranexus EMA Synerlab Miglustat Niemann-Pick C
PRESS RELEASE

published on 10/17/2024 at 18:00, 1 year 9 months ago

THERANEXUS JOINS UP WITH SYNERLAB TO PREPARE THE COMMERCIALIZATION OF ITS PEDIATRIC FORMULATION IN NIEMANN-PICK TYPE C DISEASE
Theranexus partners with Synerlab to produce oral solution of miglustat for Niemann-Pick type C disease, aiming for EMA approval and commercialization by 2026. Novel pediatric formulation Mig-OS provides new therapeutic option for NPC patients

Theranexus Synerlab Miglustat Niemann-Pick Type C Disease EMA Approval
BRIEF

published on 09/26/2024 at 18:05, 1 year 10 months ago

Theranexus announces its financial results for the first half of 2024

Financial Results Cost Reduction Biopharmaceutical Theranexus Batten-1
PRESS RELEASE

published on 09/26/2024 at 18:00, 1 year 10 months ago

THERANEXUS ANNOUNCES FIRST HALF 2024 FINANCIAL RESULTS
Theranexus reports cost reduction success and positive first half 2024 financial results, led by completion of Batten-1 clinical trial and operating grants

Financial Results Cost Reduction Clinical Trial Theranexus Batten-1
BRIEF

published on 07/11/2024 at 18:50, 2 years ago

Theranexus announces its cash flow as of June 30, 2024 and details the progress of Batten-1

Treasury Funding Theranexus Batten-1 Neurological Disease

Accesswire

Published on 07/29/2026 at 08:05, 4 hours 25 minutes ago

Tocvan Announces Strategic Management Restructuring to Align Leadership with Growth and Production Objectives
Published on 07/29/2026 at 04:38, 7 hours 52 minutes ago

CoTec Holdings Corp. Engages Epstein Research
Published on 07/29/2026 at 02:27, 10 hours 3 minutes ago

Presentation to Tactic Conference
Published on 07/28/2026 at 23:13, 13 hours 17 minutes ago

Nepra Foods Executes Definitive Agreement to Acquire Idaho Beverage Manufacturing Business
Published on 07/28/2026 at 22:05, 14 hours 25 minutes ago

Unusual Machines Adopts Performance-Based Executive Compensation

View all ACCESSWIRE

EQS Group

Published on 07/29/2026 at 12:06, 23 minutes ago

Holding(s) in Company
Published on 07/29/2026 at 12:05, 25 minutes ago

VeroNex VERIFIZIERT™: European AI Verification is Ready
Published on 07/29/2026 at 12:05, 25 minutes ago

Lockton Launches Global Data Centers & Digital Infrastructure Practice
Published on 07/29/2026 at 11:53, 37 minutes ago

Logwin reports revenue growth in the first half of 2026
Published on 07/29/2026 at 11:44, 46 minutes ago

CFO Isabelle Damen to leave ElringKlinger at year-end 2026

Les Echos

Published on 07/29/2026 at 12:05, 25 minutes ago

CNP Assurances wins the call for tenders for the personal risk insurance of 62,000 employees of the City of Paris and its partners
Published on 07/29/2026 at 08:30, 4 hours ago

SUEZ delivers a solid first half of 2026
Published on 07/29/2026 at 08:15, 4 hours 15 minutes ago

Winamp Announces Strategic Partnership with Deezer to Power the Next Generation of Its Iconic Music Player
Published on 07/29/2026 at 08:00, 4 hours 30 minutes ago

Neoen doubles size of Goyder Battery after signing two 15-year capacity contracts in South Australia
Published on 07/28/2026 at 19:21, 17 hours 9 minutes ago

Saint-Gobain signs a framework agreement with Microsoft and enhances its leadership in AI for construction

View all LES ECHOS COMFI WIRE